Clinical Trial Update: Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating multiple-dose Genakumab injections in Chinese healthy adults, with Interstitial Lung Disease listed as the condition studied.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Drugs mentioned

• Genakumab

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Interstitial Lung Disease | Phase 1 | Status: COMPLETED